Heartwood Wealth Advisors LLC Sells 24 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Heartwood Wealth Advisors LLC trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.0% in the fourth quarter, Holdings Channel.com reports. The fund owned 572 shares of the healthcare conglomerate’s stock after selling 24 shares during the quarter. Heartwood Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $289,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the company. VitalStone Financial LLC lifted its position in shares of UnitedHealth Group by 600.0% during the second quarter. VitalStone Financial LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $36,000 after purchasing an additional 60 shares in the last quarter. Linscomb Wealth Inc. increased its position in shares of UnitedHealth Group by 11.1% during the second quarter. Linscomb Wealth Inc. now owns 1,054 shares of the healthcare conglomerate’s stock valued at $537,000 after acquiring an additional 105 shares during the last quarter. Qsemble Capital Management LP boosted its position in UnitedHealth Group by 161.3% in the second quarter. Qsemble Capital Management LP now owns 8,414 shares of the healthcare conglomerate’s stock worth $4,285,000 after purchasing an additional 5,194 shares during the last quarter. Johnson Investment Counsel Inc. increased its stake in shares of UnitedHealth Group by 0.5% during the 2nd quarter. Johnson Investment Counsel Inc. now owns 268,033 shares of the healthcare conglomerate’s stock worth $136,499,000 after purchasing an additional 1,363 shares during the last quarter. Finally, BOKF NA grew its position in shares of UnitedHealth Group by 2.9% in the second quarter. BOKF NA now owns 66,217 shares of the healthcare conglomerate’s stock valued at $33,722,000 after purchasing an additional 1,857 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.8 %

Shares of NYSE UNH traded down $4.15 during midday trading on Friday, hitting $520.37. 3,581,933 shares of the company traded hands, compared to its average volume of 3,867,549. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The stock has a 50-day moving average price of $556.20 and a 200 day moving average price of $561.20. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The firm has a market cap of $478.89 billion, a P/E ratio of 33.90, a P/E/G ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the business earned $6.56 EPS. UnitedHealth Group’s quarterly revenue was up 9.2% compared to the same quarter last year. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.61%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is presently 54.72%.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Oppenheimer upped their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. TD Cowen raised their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Royal Bank of Canada dropped their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday, December 9th. Finally, Piper Sandler lowered their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Two equities research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $626.79.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.